Open AccessMetabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women
Author(s) -
Nathan A Summers,
Cecile Delille Lahiri,
Christine D. Angert,
Amalia Aldredge,
C. Christina Mehta,
Ighovwerha Ofotokun,
Anne Marie Kerchberger,
Deborah Gustafson,
Sheri D. Weiser,
Seble Kassaye,
Deborah KonkleParker,
Anjali Sharma,
Adaora A. Adimora,
Héctor Bolívar,
Jennifer Cocohoba,
Audrey L. French,
Elizabeth T. Golub,
Anandi N. Sheth
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002447
Subject(s) - integrase , body mass index , medicine , overweight , blood pressure , diabetes mellitus , metabolic syndrome , antiretroviral therapy , human immunodeficiency virus (hiv) , insulin resistance , obesity , viral load , endocrinology , immunology
Integrase strand transfer inhibitors (INSTIs) have been associated with weight gain among women living with HIV. We aimed to investigate the association between INSTIs and change in cardiometabolic risk indicators.